Department of Health
and Human Services (HHS)
and Human Services (HHS)
January 25, 2021
RFA-RM-21-008 - Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
This notice informs applicants of a change to the Key Dates for RFA-RM-21-008 "Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)". The Open Date, Letter of Intent Due Date, Application Due Date and Expiration Date have been extended.
The following sections of RFA-RM-21-008 "Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)" have been modified.
Currently Reads:
Part 1. Overview Information
Key Dates
Open Date (Earliest Submission Date): February 8, 2021
Letter of Intent Due Date(s): February 8, 2021
Application Due Date(s): March 08, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date: March 9, 2021
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Key Dates
Open Date (Earliest Submission Date): February 22, 2021
Letter of Intent Due Date(s): February 22, 2021
Application Due Date(s): March 22, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date: March 23, 2021
All other aspects of this FOA remain the same.
Felipe Sierra, Ph.D.
National Institute on Aging (NIA)
Telephone: 240.338.9544
Email: [email protected]